Novacyt S.A. (ALNOV.PA)

EUR 0.45

(-2.68%)

Total Debt Summary of Novacyt S.A.

Novacyt S.A.'s latest annual total debt in 2023 was 13.7 Million GBP , up 1471.56% from previous year.
Novacyt S.A.'s latest quarterly total debt in 2023 FY was 13.7 Million GBP , up 1471.56% from previous quarter.
Novacyt S.A. reported annual total debt of 872 Thousand GBP in 2022, down -53.37% from previous year.
Novacyt S.A. reported annual total debt of 1.87 Million GBP in 2021, down -21.36% from previous year.
Novacyt S.A. reported quarterly total debt of 249.07 Thousand GBP for 2023 Q1, down -71.44% from previous quarter.
Novacyt S.A. reported quarterly total debt of 389 Thousand GBP for 2023 Q2, up 56.18% from previous quarter.

Annual Total Debt Chart of Novacyt S.A. (2023 - 2011)

Historical Annual Total Debt of Novacyt S.A. (2023 - 2011)

Year	Total Debt	Total Debt Growth
2023	13.7 Million GBP	1471.56%
2022	872 Thousand GBP	-53.37%
2021	1.87 Million GBP	-21.36%
2020	2.37 Million GBP	-74.58%
2019	9.35 Million EUR	93.1%
2018	4.84 Million EUR	40.18%
2017	3.45 Million EUR	-35.18%
2016	5.33 Million EUR	114.2%
2015	2.48 Million EUR	175.61%
2014	903.14 Thousand EUR	48.31%
2013	608.96 Thousand EUR	20.58%
2012	505.03 Thousand EUR	-41.02%
2011	856.3 Thousand EUR	0.0%

Year	Total Debt	Total Debt Growth
2023 FY	13.7 Million GBP	1471.56%
2023 Q1	249.07 Thousand GBP	-71.44%
2023 Q2	389 Thousand GBP	56.18%
2023 Q4	13.7 Million GBP	0.0%
2022 Q4	872 Thousand GBP	190.94%
2022 Q2	1.67 Million GBP	0.0%
2022 FY	872 Thousand GBP	-53.37%
2022 Q3	299.71 Thousand GBP	-82.06%
2021 Q2	2.07 Million GBP	0.0%
2021 FY	1.87 Million GBP	-21.36%
2021 Q4	1.87 Million GBP	0.0%
2020 Q2	2.07 Million EUR	0.0%
2020 Q4	2.37 Million GBP	0.0%
2020 FY	2.37 Million GBP	-74.58%
2019 FY	9.35 Million EUR	93.1%
2019 Q2	7.79 Million EUR	0.0%
2019 Q4	10.95 Million EUR	0.0%
2018 Q4	4.84 Million EUR	0.0%
2018 FY	4.84 Million EUR	40.18%
2018 Q2	5.56 Million EUR	0.0%
2017 Q4	3.45 Million EUR	0.0%
2017 FY	3.45 Million EUR	-35.18%
2017 Q2	4.73 Million EUR	0.0%
2016 Q4	5.33 Million EUR	0.0%
2016 FY	5.33 Million EUR	114.2%
2016 Q2	4.79 Million EUR	0.0%
2015 Q4	2.48 Million EUR	0.0%
2015 Q2	986.44 Thousand EUR	0.0%
2015 FY	2.48 Million EUR	175.61%
2014 Q2	918.78 Thousand EUR	0.0%
2014 Q4	903.14 Thousand EUR	0.0%
2014 FY	903.14 Thousand EUR	48.31%
2013 FY	608.96 Thousand EUR	20.58%
2012 FY	505.03 Thousand EUR	-41.02%
2011 FY	856.3 Thousand EUR	0.0%

Peer Total Debt Comparison of Novacyt S.A.

Name	Total Debt	Total Debt Difference
Affluent Medical SA	17.13 Million EUR	20.019%
Bluelinea Société Anonyme	3.61 Million EUR	-278.621%
Carmat SA	57.64 Million EUR	76.229%
Diagnostic Medical Systems S.A.	16.28 Million EUR	15.849%
Euromedis Groupe	10.01 Million EUR	-36.804%
Eurobio Scientific Société anonyme	100.63 Million EUR	86.382%
Ikonisys S.A.	3.2 Million EUR	-327.249%
Implanet S.A.	6.15 Million EUR	-122.793%
Median Technologies SA	23.01 Million EUR	40.451%
SpineGuard SA	3.08 Million EUR	-344.199%
Theraclion SA	1.95 Million EUR	-602.504%
Euroapi S.A.	225.5 Million EUR	93.923%
Guerbet SA	383.87 Million EUR	96.43%